FAIM
MBII

Financial Advocates Investment Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Financial Advocates Investment Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-72,145
Closed -$65K – 826
2021
Q3 		$65K Buy
72,145
+6,835
+10% +$8.23K ﹤0.01% 733
2021
Q2 		$108K Hold
65,310
– – 0.01% 720
2021
Q1 		$137K Buy
65,310
+22,425
+52% +$46.6K 0.01% 726
2020
Q4 		$54K Buy
42,885
+11,960
+39% +$14.3K ﹤0.01% 705
2020
Q3 		$38K Buy
+30,925
New +$37.6K ﹤0.01% 619

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Advocates Investment Management's MBII Position: Q4 2021 in Review

Financial Advocates Investment Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2021, closing a stake of 72,145 shares — an estimated $65K sold.

Financial Advocates Investment Management first reported a position in MBII in Q3 2020 and held it in 5 quarters. The position peaked at $137K in Q1 2021. 74 funds tracked by Wall St. Rank hold MBII as of Q4 2021.

  • Financial Advocates Investment Management reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2021 after selling out during the quarter.
  • Financial Advocates Investment Management sold 72,145 Marrone Bio Innovations, Inc. shares in Q4 2021, an estimated $65K.
  • Financial Advocates Investment Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2020 and held it in 5 quarters.
  • Financial Advocates Investment Management's Marrone Bio Innovations, Inc. position peaked at $137K in Q1 2021.
  • 74 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2021.

Based on Financial Advocates Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.